網膜イメージング装置の世界市場

網膜イメージング装置の世界市場は2030年までに58億米ドルに達する見込み

2024年に39億米ドルと推定される網膜イメージング装置の世界市場は、2024年から2030年にかけてCAGR 6.7%で成長し、2030年には58億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである光コヒーレンストモグラフィは、CAGR 8.7%を記録し、分析期間終了時には15億米ドルに達すると予測されています。フルオレセイン血管造影装置セグメントの成長率は、分析期間でCAGR 4.6%と推定されます。

米国市場は11億米ドル、中国はCAGR10.8％で成長予測

米国の網膜イメージング装置市場は2024年に11億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.6%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の網膜イメージング装置市場- 主要動向と促進要因のまとめ

網膜イメージング装置が現代の眼科医療に欠かせない存在になりつつある理由とは？

網膜イメージング装置は、糖尿病性網膜症、緑内障、黄斑変性症、網膜剥離など、さまざまな眼疾患の早期発見とモニタリングを可能にし、眼科診断の要となっています。視覚関連疾患の世界の負担増に伴い、高解像度画像処理技術に対する需要は臨床と研究の両面で急増しています。これらの装置は、網膜の構造的・機能的完全性に関する比類のない洞察を提供し、眼科医が状態を初期段階で診断し、タイムリーな介入を実施することを可能にします。さらに、糖尿病の蔓延と人口の高齢化が世界的に進んでいるため、定期的な眼科検診が病気の予防と管理に不可欠となり、網膜画像ソリューションの採用がさらに進んでいます。人工知能（AI）と遠隔眼科サービスの統合も網膜診断の利用しやすさを拡大し、プライマリケアや遠隔地のヘルスケア環境で高精度の画像診断がより広く利用できるようになりました。

技術革新は網膜画像診断能力をどのように向上させているか？

網膜画像診断技術の進化は、画像の解像度、スピード、診断精度に大きな進歩をもたらしました。光干渉断層計（OCT）は網膜の断面をミクロン単位で詳細に画像化し、網膜の層や異常を正確に可視化することで、この分野に革命をもたらしました。さらに、眼底写真とフルオレセイン血管造影は、網膜に影響を及ぼす血管状態の評価能力を向上させました。超広視野画像（UWF）は診断範囲をさらに拡大し、網膜をより包括的に捉え、網膜周辺部の病態の早期発見を容易にしています。AIを活用した画像解析の統合は、疾患検出とリスク評価を自動化することで診断効率を高め、ヘルスケア専門家の負担を軽減しています。さらに、ポータブルおよびハンドヘルドの開発により、特に従来の眼科インフラが不足しているような医療サービスが行き届いていない地域において、診断がより利用しやすくなっています。

網膜イメージング装置の普及を促進する市場動向とは？

予防ヘルスケアと病気の早期発見が重視されるようになったことが、眼科クリニック、病院、研究機関における網膜イメージング装置の導入に大きく影響しています。遠隔眼科サービスの拡大により、デジタル網膜画像の需要がさらに高まり、遠隔診察やAIによる診断が可能になりました。さらに、糖尿病網膜症スクリーニング・プログラムや視力健康意識向上キャンペーンを推進する政府の取り組みが、高度画像技術の広範な導入を後押ししています。また、OCT、眼底写真、血管造影を組み合わせたマルチモーダル画像システムの利用が増加していることも、診断精度と効率を高めています。さらに、AIを活用したクラウドベースのイメージング・プラットフォームの人気が高まっており、ヘルスケア専門家間のデータ管理とコラボレーションが合理化され、患者の治療成績が向上しています。網膜画像診断が進化を続けるなか、個別化医療、神経眼科、網膜バイオマーカーによる全身性疾患の検出など、新たな市場機会が生まれつつあります。

網膜イメージング装置市場の主な成長促進要因は？

世界の網膜イメージング装置市場の成長は、急速な技術進歩、網膜疾患の有病率の増加、遠隔眼科ソリューションの採用拡大など、いくつかの要因によってもたらされます。AIを活用した診断ツールの開発により、網膜スクリーニングの効率性とアクセシビリティが大幅に向上し、ヘルスケアプロバイダーの採用率が高まっています。さらに、新興国におけるヘルスケアインフラの拡充は、高度な眼科診断へのアクセスを増加させ、市場の成長をさらに促進しています。ポータブルでユーザーフレンドリーな網膜画像ソリューションに対する需要の高まりも、コンパクトでコスト効率の高い機器の技術革新を後押ししています。網膜イメージングを全身疾患診断、特に心臓病学や神経学と統合する傾向が強まっており、市場拡大の新たな道が開かれつつあります。ヘルスケアシステムが早期発見とデジタルヘルスの統合を優先する中、網膜イメージング装置市場は持続的な成長を遂げ、眼科診断と患者中心のケアの未来を形成する態勢が整っています。

セグメント

デバイス（光干渉断層計、フルオレセイン血管造影デバイス、眼底カメラ、網膜超音波、超広視野網膜イメージング装置、広視野網膜イメージング装置、その他デバイス）、適応症（糖尿病網膜症、加齢黄斑変性、緑内障、網膜静脈閉塞症、その他の適応症）、用途（疾患診断、治療モニタリング、研究開発）、最終用途（病院、眼科クリニック、外来手術センター、その他の最終用途）

調査対象企業の例

• Canon Medical Systems Corporation
• Carl Zeiss Meditec AG
• CenterVue S.p.A.
• Epipole Ltd.
• Eyenuk Inc.
• Forus Health Pvt Ltd
• Fundus Photo
• Heidelberg Engineering GmbH
• iCare USA Inc.
• IISCIENCE
• Imagine Eyes
• Intalight
• JuneBrain
• Lumibird Medical
• Lumithera, Inc.
• Mediwhale
• NIDEK CO., LTD.
• Novai Ltd.
• Optina Diagnostics
• Optomed Plc

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Retinal Imaging Devices Market to Reach US$5.8 Billion by 2030

The global market for Retinal Imaging Devices estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Optical Coherence Tomography, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Fluorescein Angiography Devices segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 10.8% CAGR

The Retinal Imaging Devices market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Retinal Imaging Devices Market - Key Trends & Drivers Summarized

Why Are Retinal Imaging Devices Becoming Indispensable in Modern Ophthalmology?

Retinal imaging devices have become a cornerstone of ophthalmic diagnostics, enabling early detection and monitoring of various eye diseases, including diabetic retinopathy, glaucoma, macular degeneration, and retinal detachment. With the rising global burden of vision-related disorders, the demand for high-resolution imaging technologies has surged in both clinical and research settings. These devices offer unparalleled insights into the structural and functional integrity of the retina, allowing ophthalmologists to diagnose conditions in their earliest stages and implement timely interventions. Additionally, the increasing prevalence of diabetes and aging populations worldwide has further driven the adoption of retinal imaging solutions, as regular eye screenings become essential for disease prevention and management. The integration of artificial intelligence (AI) and teleophthalmology services has also expanded the accessibility of retinal diagnostics, making high-precision imaging more widely available in primary care and remote healthcare settings.

How Are Technological Innovations Enhancing Retinal Imaging Capabilities?

The evolution of retinal imaging technology has brought about significant advancements in imaging resolution, speed, and diagnostic accuracy. Optical coherence tomography (OCT) has revolutionized the field by providing cross-sectional imaging of the retina with micron-level detail, enabling precise visualization of retinal layers and abnormalities. Additionally, fundus photography and fluorescein angiography have improved the ability to assess vascular conditions affecting the retina. Ultra-widefield imaging (UWF) has further expanded the diagnostic scope, capturing a more comprehensive view of the retina and facilitating early detection of peripheral retinal pathologies. The integration of AI-powered image analysis has enhanced diagnostic efficiency by automating disease detection and risk assessment, reducing the burden on healthcare professionals. Furthermore, the development of portable and handheld retinal imaging devices has made diagnostics more accessible, particularly in underserved regions where traditional ophthalmic infrastructure may be lacking.

What Market Trends Are Driving the Adoption of Retinal Imaging Devices?

The growing emphasis on preventive healthcare and early disease detection has significantly influenced the adoption of retinal imaging devices across ophthalmic clinics, hospitals, and research institutions. The expansion of teleophthalmology services has further increased demand for digital retinal imaging, allowing for remote consultations and AI-assisted diagnoses. Additionally, government initiatives promoting diabetic retinopathy screening programs and vision health awareness campaigns have driven the widespread implementation of advanced imaging technologies. The increasing use of multimodal imaging systems, which combine OCT, fundus photography, and angiography, has also enhanced diagnostic accuracy and efficiency. Furthermore, the rising popularity of AI-enabled cloud-based imaging platforms has streamlined data management and collaboration among healthcare professionals, improving patient care outcomes. As retinal imaging continues to evolve, new market opportunities are emerging in personalized medicine, neuro-ophthalmology, and systemic disease detection through retinal biomarkers.

What Are the Key Growth Drivers of the Retinal Imaging Devices Market?

The growth in the global retinal imaging devices market is driven by several factors, including rapid technological advancements, increasing prevalence of retinal disorders, and expanding adoption of teleophthalmology solutions. The development of AI-driven diagnostic tools has significantly improved the efficiency and accessibility of retinal screenings, leading to higher adoption rates among healthcare providers. Additionally, the expansion of healthcare infrastructure in emerging economies has increased access to advanced ophthalmic diagnostics, further fueling market growth. The rising demand for portable and user-friendly retinal imaging solutions has also driven innovation in compact and cost-effective devices. The growing trend of integrating retinal imaging with systemic disease diagnostics, particularly in cardiology and neurology, is opening new avenues for market expansion. As healthcare systems prioritize early detection and digital health integration, the retinal imaging devices market is poised for sustained growth, shaping the future of ophthalmic diagnostics and patient-centered care.

SCOPE OF STUDY:

The report analyzes the Retinal Imaging Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices, Other Devices); Indication (Diabetic Retinopathy, Age-Related Macular Degeneration, Glaucoma, Retinal Vein Occlusion, Other Indications); Application (Disease Diagnosis, Treatment Monitoring, Research & Development); End-Use (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Canon Medical Systems Corporation
• Carl Zeiss Meditec AG
• CenterVue S.p.A.
• Epipole Ltd.
• Eyenuk Inc.
• Forus Health Pvt Ltd
• Fundus Photo
• Heidelberg Engineering GmbH
• iCare USA Inc.
• IISCIENCE
• Imagine Eyes
• Intalight
• JuneBrain
• Lumibird Medical
• Lumithera, Inc.
• Mediwhale
• NIDEK CO., LTD.
• Novai Ltd.
• Optina Diagnostics
• Optomed Plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Retinal Imaging Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Burden of Diabetic Retinopathy and AMD Propels Adoption of Advanced Retinal Imaging Devices
  • Increased Demand for Non-Invasive and Real-Time Imaging Throws the Spotlight on OCT and Fundus Technologies
  • Expansion of Teleophthalmology and AI-Assisted Screening Platforms Strengthens Business Case for Portable Imaging Systems
  • Technological Advancements in Widefield Imaging and Autofluorescence Drive Early Detection Capabilities
  • Integration of Retinal Imaging With Electronic Health Records Enhances Longitudinal Monitoring and Clinical Decision Making
  • Surge in AI Algorithms for Automated Disease Classification Accelerates Workflow Efficiency
  • Growth in Pediatric and Geriatric Ophthalmology Expands Demand for Specialized Imaging Modalities
  • Rising Number of Vision Screening Programs in Schools and Community Clinics Supports Market Expansion
  • Increased Adoption of OCT-Angiography Fuels Market for Detailed Microvascular Analysis Tools
  • OEM Collaborations With Healthcare Networks Drive Standardization of Diagnostic Protocols
  • Use of Imaging in Surgical Planning and Postoperative Monitoring Enhances Clinical Accuracy and Safety
  • Development of Smartphone-Enabled Imaging Attachments Drives Accessibility in Remote and Low-Resource Settings
  • Global Push for Early Detection of Eye Diseases Strengthens Screening Infrastructure in Emerging Economies
  • Integration of Cloud-Based Imaging Storage and Remote Reporting Enhances Data Accessibility and Sharing
  • Growing Use of Retinal Imaging for Systemic Disease Detection Expands Interdisciplinary Applications
  • Demand for Compact and Handheld Imaging Devices Supports Outpatient and Home Care Ophthalmology Models
  • Introduction of AI-Driven Real-Time Feedback Enhances Clinician Training and Diagnostic Quality
  • Regulatory Approvals for AI-Integrated Diagnostic Devices Boost Commercialization and Clinical Deployment
  • Increased Investment in Mobile Screening Units and Vision Vans Creates Public Health Opportunities
  • Shift Toward Value-Based Eye Care Models Reinforces Preventive Imaging as a Clinical Standard
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Retinal Imaging Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Optical Coherence Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Fluorescein Angiography Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Fluorescein Angiography Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Fluorescein Angiography Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Fundus Cameras by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Fundus Cameras by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Fundus Cameras by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Retinal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Retinal Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Retinal Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ultra Widefield Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ultra Widefield Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ultra Widefield Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Widefield Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Widefield Retinal Imaging Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Widefield Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Glaucoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Glaucoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Glaucoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Retinal Vein Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Retinal Vein Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Retinal Vein Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Diabetic Retinopathy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Age-Related Macular Degeneration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Age-Related Macular Degeneration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Age-Related Macular Degeneration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Treatment Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Research & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Research & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Research & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Ophthalmology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Retinal Imaging Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Retinal Imaging Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Retinal Imaging Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Retinal Imaging Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Retinal Imaging Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Retinal Imaging Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Retinal Imaging Devices by Device - Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Retinal Imaging Devices by Device - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Fluorescein Angiography Devices, Fundus Cameras, Retinal Ultrasound, Ultra Widefield Retinal Imaging Devices, Widefield Retinal Imaging Devices and Other Devices for the Years 2015, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Retinal Imaging Devices by Indication - Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Retinal Imaging Devices by Indication - Percentage Breakdown of Value Sales for Glaucoma, Retinal Vein Occlusion, Other Indications, Diabetic Retinopathy and Age-Related Macular Degeneration for the Years 2015, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Retinal Imaging Devices by Application - Disease Diagnosis, Treatment Monitoring and Research & Development Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Retinal Imaging Devices by Application - Percentage Breakdown of Value Sales for Disease Diagnosis, Treatment Monitoring and Research & Development for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Retinal Imaging Devices by End-Use - Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Retinal Imaging Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION